Target
Bromodomain-containing protein 4 [42-168]
Ligand
BDBM318493
Substrate
n/a
Meas. Tech.
AlphaScreen Assay A1
IC50
<100±n/a nM
Citation
 Combs, APSparks, RBMaduskuie, Jr., TPRodgers, JD Tricyclic heterocycles as BET protein inhibitors US Patent  US10464947 Publication Date 11/5/2019 
Target
Name:
Bromodomain-containing protein 4 [42-168]
Synonyms:
BRD4 | BRD4 BD1 (aa 42-168) | BRD4_HUMAN | Bromodomain-containing protein 4 Bromo Domain 1 | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15054.68
Organism:
Homo sapiens (Human)
Description:
O60885[42-168]
Residue:
127
Sequence:
STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM318493
Synonyms:
7-(3,5-Dimethylisoxazol-4-yl)-4-phenyl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazine | US10464947, Example 39 | US11498926, Example 39 | US9624241, Example 39
Type:
Small organic molecule
Emp. Form.:
C20H17N3O2
Mol. Mass.:
331.3679
SMILES:
Cc1noc(C)c1-c1ccc2ncn3C(COc1c23)c1ccccc1 |(-.15,-6.16,;-1.48,-5.39,;-2.95,-5.87,;-3.85,-4.62,;-2.95,-3.37,;-3.72,-2.04,;-1.48,-3.85,;-.15,-3.08,;1.18,-3.85,;2.52,-3.08,;2.52,-1.54,;3.85,-.77,;2.72,.77,;1.18,.77,;-.15,1.54,;-1.48,.77,;-1.48,-.77,;-.15,-1.54,;1.18,-.77,;-.15,3.08,;1.18,3.85,;1.18,5.39,;-.15,6.16,;-1.48,5.39,;-1.48,3.85,)|
Structure:
Search PDB for entries with ligand similarity: